Ignite Creation Date:
2024-05-05 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00419146
Status:
COMPLETED
Last Update Posted:
2011-01-04
First Post:
2007-01-05
Brief Title:
Treatment of Schizophrenia With an Omega-3 Fatty Acid EPA and Antioxidants
Sponsor:
University Hospital Aker
Organization:
Oslo University Hospital
Organization Data
Organization:
Oslo University Hospital
Class:
OTHER
Study ID:
LA01070001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Hospital Aker
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Norwegian University of Science and Technology | OTHER |
| Diakonhjemmet Hospital | OTHER |
| Stanley Medical Research Institute | OTHER |
| Laxdale Ltd | UNKNOWN |
| Scandinavian Society for Psychopharmacology | UNKNOWN |
| Shipowner Emil Strays legacy | UNKNOWN |
| Johanne and Einar Eilertsens research fund | UNKNOWN |
| AstraZeneca | INDUSTRY |
| Solveig and Johan P Sommers foundation | UNKNOWN |
| Josef and Haldis Andresens legacy | UNKNOWN |
| University of Oslo | OTHER |